Work

A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2015.01.038

Authors: John M. Kane, Aleksandar Skuban, John Ouyang, Mary Hobart, Stephanie Pfister, Robert D. McQuade, Margaretta Nyilas, William H. Carson, Raymond Sanchez, Hans Eriksson

Institutions: Zucker Hillside Hospital, Otsuka (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States), Lundbeck (Denmark)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1990121386

FWCI: 15.2

Cites: 34

Cited by: 325

Related to: 10